Position in RYTM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$665,735
-$4,402,044 QoQ
Shares Held
5,996
-88.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#174
of 299 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$1,218,310
PutShares
23,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. RYTM ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in RYTM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $665,735 | 5,996 | Shares | Sole | 2026-08-03 | |
| 2025-09-30 | $5,067,779 | 50,181 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,218,310 | 23,000 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $1,897,809 | 35,828 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,080,265 | 144,342 | Shares | Sole | 2025-02-13 | |
| 2023-06-30 | $6,522,471 | 395,541 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,457,798 | 137,769 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $4,688,638 | 191,373 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $650,975 | 49,845 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||